Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

por Sims, A H, Zweemer, A JM, Nagumo, Y, Faratian, D, Muir, M, Dodds, M, Um, I, Kay, C, Hasmann, M, Harrison, D J, Langdon, S P
Publicado 2012